Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: method of inhibiting Hsp90 with novobiocin

Aug. 3, 1999

Ontogen completes phase I bioavailability study of MDR-modulating compound

Aug. 3, 1999

Solimastat is a potent MMP inhibitor with significant advantages over related compounds

Aug. 2, 1999

New apoptosis inducers claimed by Takara Shuzo

Aug. 2, 1999

Anti-VEGF enhances efficacy of radiation therapy

Aug. 2, 1999

NuOncology Labs awarded U.S. patent for anticancer compounds

Aug. 2, 1999

Pharmacokinetic and efficacy studies reported for novel prostate cancer drug

Aug. 2, 1999

Bavarian Nordic to begin phase II study of pancreatic cancer therapy

July 30, 1999

Pilot trial commences for Eligix's BCell-HDM product

July 30, 1999

Disaccharide ester with anti-TNF-alpha effects and chemopreventive efficacy

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...